Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rui Su

Showing results (761-770 of 775) with videos related to

Pageof 78
Sort By:
Nature Cancer|February 27, 2024
Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunityHaojie Dong, Xin He, Lei Zhang, et al.
Nature Communications|December 14, 2017
Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemiaXi Jiang, Chao Hu, Kyle Ferchen, et al.
Journal of Hematology & Oncology|February 2, 2024
METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translationMeilin Xue, Lei Dong, Honghai Zhang, et al.
Cell Stem Cell|August 4, 2023
TET2-mediated mRNA demethylation regulates leukemia stem cell homing and self-renewalYangchan Li, Meilin Xue, Xiaolan Deng, et al.
Nature Communications|February 11, 2018
Author Correction: Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemiaXi Jiang, Chao Hu, Kyle Ferchen, et al.
Nature Communications|September 1, 2023
Acquired miR-142 deficit in leukemic stem cells suffices to drive chronic myeloid leukemia into blast crisisBin Zhang, Dandan Zhao, Fang Chen, et al.
Science Translational Medicine|March 29, 2023
Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemiaZhenhua Chen, Keren Zhou, Jianhuang Xue, et al.
Blood|June 5, 2026
Targeting the METTL1/m⁷G axis as a therapeutic strategy in myeloid leukemiaLili Ren, Honghai Zhang, Olga Bobileva, et al.
Cancer Cell|June 13, 2020
Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune EvasionRui Su, Lei Dong, Yangchan Li, et al.
Nature|March 15, 2019
Histone H3 trimethylation at lysine 36 guides m<sup>6</sup>A RNA modification co-transcriptionallyHuilin Huang, Hengyou Weng, Keren Zhou, et al.
Pageof 78

Showing results (761-770 of 775) with videos related to

Sort By:
Pageof 78
Nature Cancer|February 27, 2024
Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunityHaojie Dong, Xin He, Lei Zhang, et al.
Nature Communications|December 14, 2017
Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemiaXi Jiang, Chao Hu, Kyle Ferchen, et al.
Journal of Hematology & Oncology|February 2, 2024
METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translationMeilin Xue, Lei Dong, Honghai Zhang, et al.
Cell Stem Cell|August 4, 2023
TET2-mediated mRNA demethylation regulates leukemia stem cell homing and self-renewalYangchan Li, Meilin Xue, Xiaolan Deng, et al.
Nature Communications|February 11, 2018
Author Correction: Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemiaXi Jiang, Chao Hu, Kyle Ferchen, et al.
Nature Communications|September 1, 2023
Acquired miR-142 deficit in leukemic stem cells suffices to drive chronic myeloid leukemia into blast crisisBin Zhang, Dandan Zhao, Fang Chen, et al.
Science Translational Medicine|March 29, 2023
Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemiaZhenhua Chen, Keren Zhou, Jianhuang Xue, et al.
Blood|June 5, 2026
Targeting the METTL1/m⁷G axis as a therapeutic strategy in myeloid leukemiaLili Ren, Honghai Zhang, Olga Bobileva, et al.
Cancer Cell|June 13, 2020
Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune EvasionRui Su, Lei Dong, Yangchan Li, et al.
Nature|March 15, 2019
Histone H3 trimethylation at lysine 36 guides m<sup>6</sup>A RNA modification co-transcriptionallyHuilin Huang, Hengyou Weng, Keren Zhou, et al.
Pageof 78